Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iDC for New Onset Type 1 Diabetes Mellitus
NCT01947569Phase 2Unknown
- Sponsor
- DiaVacs, Inc.
- Start
- Oct 2013
- Primary completion
- Nov 2014
- Countries
- 1
01
Overview
A Phase 2 trial of diabetes-suppressive dendritic cell vaccine in type 1 diabetes mellitus (T1D), sponsored by DiaVacs, Inc.. Status: unknown.
02
Drugs
diabetes-suppressive dendritic cell vaccine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01947569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01947569.